Australia’s largest life sciences conference heading to Perth

Business Events Perth has secured Australia’s largest life sciences conference, AusBiotech, to come to Western Australia in 2022.

AusBiotech 2022 is expected to attract over 1000 delegates to Perth, as well as bring new commercial opportunities to Western Australia’s thriving biotechnology industry.

“Western Australia’s life science industry is one of the fastest growing in Australia, with the total economic contribution estimated to be $29.7 billion last year,” Business Events Perth chief executive Gareth Martin said.

“The AusBiotech conference and Australia’s leading life sciences investment event will be held in our thriving state is an important opportunity to showcase Western Australia’s significant expertise in the biotech and life sciences sector, not only to the rest of Australia, but also to the world.”

Running in conjunction with the conference is the Australia Biotech Invest & Partnering event, which will provide opportunities for local companies and professional service providers to connect with key stakeholders and investors.

There are currently around 40 biotechnology and pharmaceutical companies and more than 50 medtech and digital health companies based in Western Australia, along with 22 research institutions and almost 65 services and support organisations.

“AusBiotech is thrilled to be partnering with Business Events Perth and the WA Government to bring two of Australia’s premier life science events to Perth in 2022, for the first time in more than 15 years,” said Lorraine Chiroiu, CEO of AusBiotech.

“The mature sector continues to flourish and deliver social and economic benefits to the country, and these platforms offer critical opportunities for industry to engage with each other and with potential investors and partners.”

Business Events Perth partnered with the Western Australian Department of Jobs, Tourism, Science and Innovation and the City of Perth to secure the event.